AES Corp vs Tilray Brands Inc — how do they compare? AES Corp trades at $14.72 (market cap $10.51B), while Tilray Brands Inc trades at $4.77 (market cap $601.34M). The key difference: AES Corp is far larger — about 17.5× Tilray Brands Inc's market cap, and AES Corp pays a 4.78% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals.
| AES | TLRY | |
|---|---|---|
Market Cap | $10.51B | $601.34M |
Sector | Utilities | Health |
52-Week High | $17.28 | $21.00 |
52-Week Low | $12.51 | $3.88 |
Enterprise Value | $40.77B | $768.47M |
Dividend Yield | 4.78% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TLRY trades at $4.57, up 2.93% with a bullish technical signal, though recent earnings misses and negative profitability metrics highlight fundamental challenges. The company reported record fiscal 2026 revenue of $915 million but continues to post significant net losses. Analyst sentiment is mixed with 25% buy ratings, while technical indicators show RSI near overbought levels with key support at $4.
Outlook remains cautious due to persistent losses and high valuation multiples, though revenue growth and diversification into beverages offer potential upside. Key risks include execution challenges, cannabis regulatory uncertainty, and competitive pressures in the consumer goods space.
Trailing returns across standard periods
AES is a global power company operating across 14 countries and 4 continents. Its current generation portfolio as of year-end 2021 consists of over 31 gigawatts of generation, with the generation mix composed of renewables (43%), gas (32%), coal (23%), and oil (2%). The company has 3.5 gigawatts of generation under construction. AES has majority ownership and operates six electric utilities distributing power to 2.6 million customers.
Read more on AES →Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →